Skip to content
ESIC Drug Testing Samples Report
- Who
- Director (Medical) Delhi/Noida +2 more
- Action
- Review the drug sample testing report to prevent repetition of tests for already examined medicines.
What changed
The Employees' State Insurance Corporation issues a report on drug test samples sent from regional offices and hospitals to prevent the repetition of tested medicines. Director Medical Delhi and Noida, Medical Superintendents of all ESIC hospitals, and Directors of ESIS hospitals in all states receive the document for information and necessary action.
What you must do
- Review the drug sample testing report to prevent repetition of tests for already examined medicines.
Who is affected
- Director (Medical) Delhi/Noida
Document text
कर्मचारी राज्य बीमा निगम (श्रम एवं रोजगार मंत्रालय, भारत सरकार) EMPLOYEES' STATE INSURANCE CORPORATION (Ministry of Labour & Employment, Govt. of India)
मुख्यालय Headquarters पंचदीप भवन, सी.आई.जी. रोड, नई दिल्ली-110002 PANCHDEEP BHAWAN, C.I.G. MARG, NEW DELHI-110 002 Phone: 011-23604700 Email: dir-gen@esic.nic.in Website: www.esic.nic.in / www.esic.in
सं.- U/25/12/Drug Policy/2014-Med.V Pt. II / 421
दिनांक:
सेवा में,
Director (Medical) Delhi/Noida Medical Superintendent- All ESIC Hospitals Director ESIS Hospital- All States
विषय : दवा के नमूनों की जांच/परीक्षण से संबंधित संदर्भ: No. U-25/12/Drug Policy/2014-Med.V Part-I, Dated 21.01.15
महोदय,
उपरोक्त विषय के संदर्भ में क.रा.बी.निगम के विभिन्न कार्यालयों/अस्पतालों से प्राप्त दवा के नमूनों की जांच/परीक्षण से संबंधित रिपोर्ट संलग्नक के साथ प्रेषित की जा रही है, ताकि जिन दवाईयों की जांच/परीक्षण करवाई जा चुकी है उनका पुनरावृत्ति (Repetition) न हो सके।
यह आपकी जानकारी एवं आवश्यक कार्रवाई हेतु प्रस्तुत है।
संलग्नक:- यथोपरि
प्रतिलिपि:
- वेबसाइट समाग्री प्रबंधक क. रा. बी. नि. मुख्यालय, वेबसाइट पर अपलोड करने के अनुरोध के साथ प्रेषित।
- गार्ड फाइल।
Digitally signed by Sanjiv Kochhar Date: 20-08-2025 (26:55:58) उप वि. आयुक्त (आर.सी.)
Ref. No. U-25/12/Drug Policy/2016-Med-V Sub:- Sample sent for Testing Sl. No. 07
Dated:-22.01.2015 Dated:-07.08.2025
| Name of Institution:- Central Medical Stores, E.S.I. Scheme, Ahmedabad, Gujarat-380016 |
|---|
| Sr. No. | RC No. | Name of Pharmaceutical Firm | Name of Item | Item No & Page No. as per RC | Drug License Number and place of production | Batch No | D. O. Mfg & D. O. Expiry | Date of Sampling |
|---|---|---|---|---|---|---|---|---|
| 70 | 1 | 142C | Bajaj Healthcare ltd. Vadodara | Aspirin Gastro resistant tablets IP 150mg (ECOJAJ 150) | 428b/38 | G/25/1811, VADODARA | ASB01B25 | 02/25 01/27 |
| 71 | 2 | 143C | Macleods Pharmaceuticals Ltd., Maharashtra | Nebivolol Tablets IP (Nebimac5) | 1751/20 | KD/36, PALGHAR | 11240540B | 11/24 10/28 |
| 72 | 3 | 145C | MSD Pharmaceuticals pvt. Ltd., Bangalore | Sitagliptin Phosphate Tablets IP(Januvia 100mg) | 1490/11 | KTK/25A/808/2016 & MH/103697A, BANGLORE | JVC24009 | 6/24 05/27 |
| 73 | 4 | 143C | Pulse Pharmaceuticals Pvt. Ltd., Uttarakhand | Metoprolol succinate prolonged Release Tablets (Metloc ER50) | 525a/47 | 80/UA/2007, ROORKEE | MER3 294D | 11/24 10/26 |
Ref. No. U-25/12/Drug Policy/2016-Med-V Sub:- Sample sent for Testing Sl. No. 08
Dated:-22.01.2015 Dated:-07.08.2025
| Sr. No | RC NO | Name of Pharaceutical Firm | Name of Item | Item No & Page No.As per RC | Drug License Number & Place of Production | Batch No | D.O Mfg & D.O Expiry | Date Of Sampling |
|---|---|---|---|---|---|---|---|---|
| 74 | ESIC RC-152 | Glenmark Pharmaceuticals ltd. | Teneligliptin Tablets I.P. 20mg | Item No: 2034 Page No.41 | M/602/2012 Samlik,Marchak, M/602/2012Industrial Growth Centre, Near Ranipool, District: Gangtok, Sikkim: 737135. | 18250202 | 04-2025 03-2027 | 7/24/2025 |
| 75 | ESIC RC-160 | Biodeal Pharmaceuticals Limited | Telmisartan Tablet IP 40mg | Item No: 1420 Page No.10 | MNB/06/440 Vill.Saini Majra,Nalagarh-Ropar Road,Nalagarh- 174101,Distt.Solan, (H.P.),India. | 2505289 | 05-2025 04-2027 | 7/24/2025 |
| 76 | ESIC RC-149 | CMG BIOTECH PVT.LTD (UNIT II) | Sodium Bicarbonate Tablets IP (BISONATE-500) | Item No:2297 Page No.57 | NNZ/10-53 & BNZ/10-54 Plot No.58, Phase- III,Industrial Area, Sansarpur Terrace, Tehsil Jaswan, Distt.Kangra Himachal Pradesh- 176501 | CT25260479 | 06-2025 05-2027 | 7/24/2025 |
| 77 | ESIC RC-160 | Rivpra Formulation Pvt Ltd | Torsemide Tablets I.P. 20mg | Item No:1370b Page No.36 | 35/UA/2008 Plot No.8, Sector 6A,I.I.E.,SIDCUL, Haridwar-249403, Uttarakhand, INDIA | T-2505297 | 05-2025 04-2027 | 7/24/2025 |
| 78 | ESIC RC-159 | Ultra Drugs Pvt.Ltd.(Unit-II) | Febuxostat Tablets | Item No:1862 Page No.20 | MINB/17/1004 & MB/17/1005 HS No.211,K.No. 77/1,78/1 Vill.Katha,Baddi,Di stt.Solan (H.P.)173205 | UT-250906A | 06-2025 05-2027 | 7/24/2025 |
| 79 | ESIC RC-160 | CIPLA LTD. | Metoprolol Tartrate Tablets IP 50 mg(Metolar-50) | Item No:1056a Page No.34 | M/447/2007 Kumrek,Rangpo, Sikkim,737132 INDIA | 5SA1048 | 05-2025 04-2028 | 7/24/2025 |
Ref. No. U-25/12/Drug Policy/2016-Med-V Sub:- Sample sent for Testing Sl. No. 09
Dated:-22.01.2015 Dated:-07.08.2025
| Sl. No. | RC No. | Name of Pharmaceutical Firm | Name of Item | Item No: & Page No: as per RC | Drug License number & Place of production | Batch number | D. O Mfg & D. O Expiry | Date of sampling |
|---|---|---|---|---|---|---|---|---|
| 80 | 1 | 149 | HAB pharmaceuticals & Research Limited | Fluticasone Nasal Spray 50mcg. | 1935/52 | 47/UA/SC/P-2006, Dehradun | HNF2301 | 03/2025 02/2027 |
| 81 | 2 | 163 | East india pharmaceutical works limited | Salicylic Acid 6%, Benzoic Acid 12%, Hydrocortisone Acetate 0.5%, -Oint | 1241/33 | 05/RR/AP/2008/F/R(L), Telangana | SKT5022 | 03/2025 02/2028 |
| 82 | 3 | 163 | Micron pharmaceuticals | Clotrimazole Gel. 2% | 1397/37 | G/25/524, Vapi | E250612 | 06/2025 05/2027 |
| 83 | 4 | 145C | Lupin Ltd | Cephalexin Susp. 125mg/5ml. | 168/2 | 67/UA/LL/SC/P-2014, Uttarakhand | A24078MS | 08/2024 01/2026 |
| 84 | 5 | 155 | Intas pharmaceuticals Ltd | Dothiepin HCl. Tab. 25mg. | 372a/23 | G/162, Ahmedabad | V2400737 | 07/2024 06/2026 |
Source details
- Official title
- दवा के नमूनों की जांच परीक्षण से संबंधित (Hindi)
- Source
- Employees' State Insurance Corporation
- Type
- circular
- Published by source
- 21 Aug 2025
- Document number
- U/25/12/Drug Policy/2014-Med.V Pt. II / 421
- Issuing division
- Headquarters
- Coverage area
- labour